These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18807231)

  • 21. The nocebo effect: a reason for patients' non-adherence to generic substitution?
    Weissenfeld J; Stock S; Lüngen M; Gerber A
    Pharmazie; 2010 Jul; 65(7):451-6. PubMed ID: 20662309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 23. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceuticals issue brief: narrow therapeutic index drugs.
    Hackney C
    Issue Brief Health Policy Track Serv; 2000 Jul; ():1-5. PubMed ID: 11073428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prescribing drugs to patients receiving out-patient care].
    Garjón Parra FJ
    An Sist Sanit Navar; 2009; 32(1):11-21. PubMed ID: 19430507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tablet splitting].
    Quinzler R; Haefeli WE
    Ther Umsch; 2006 Jun; 63(6):441-7. PubMed ID: 16841582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm.
    Quinzler R; Schmitt SP; Pritsch M; Kaltschmidt J; Haefeli WE
    BMC Med Inform Decis Mak; 2009 Jun; 9():30. PubMed ID: 19523205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange.
    Burkhart CG
    J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740
    [No Abstract]   [Full Text] [Related]  

  • 30. [Generic medications and prescription by non-proprietary name].
    Delporte JP; Delattre L; Herné P
    Rev Med Liege; 2006; 61(5-6):459-63. PubMed ID: 16910276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. My doctor prescribed a brand-name drug, but the pharmacist filled the prescription with a generic version. Will the generic work, and is it safe?
    Rosen DS
    Health News; 2001 Mar; 7(3):10. PubMed ID: 11263084
    [No Abstract]   [Full Text] [Related]  

  • 32. Generic drugs. Save money--but is there a cost?
    Roberts SS
    Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605
    [No Abstract]   [Full Text] [Related]  

  • 33. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets.
    Cook TJ; Edwards S; Gyemah C; Shah M; Shah I; Fox T
    J Am Pharm Assoc (2003); 2004; 44(5):583-6. PubMed ID: 15496044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tablet splitting: a review of weight and content uniformity.
    Freeman MK; White W; Iranikhah M
    Consult Pharm; 2012 May; 27(5):341-52. PubMed ID: 22591978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of introducing rebate contracts to promote generic drug substitution, on doctors' prescribing practices.
    Hoffmann F; Glaeske G; Pfannkuche MS
    Dtsch Arztebl Int; 2009 Nov; 106(48):783-8. PubMed ID: 20038980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
    Felch WC
    Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131
    [No Abstract]   [Full Text] [Related]  

  • 37. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medication problems in connection with transferral between sectors].
    Christensen HR; Krølner BK
    Ugeskr Laeger; 2009 Mar; 171(10):808-11. PubMed ID: 19265608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality circles to improve prescribing of primary care physicians. Three comparative studies.
    Wensing M; Broge B; Riens B; Kaufmann-Kolle P; Akkermans R; Grol R; Szecsenyi J
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):763-9. PubMed ID: 19507170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.